Asset Details
Do you wish to reserve the book?
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
Do you wish to request the book?
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
2021
Overview
Background
Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in HCC bone metastasis.
Methods
The expression levels of lnc34a in serum samples from 157 HCC patients were detected by quantitative real-time polymerase chain reaction (PCR). Univariate analysis and multivariate analysis were performed to determine statistically significant variables.
Results
Expression levels of lnc34a in serum from HCC patients with bone metastasis were significantly higher than those without bone metastasis. The high expressions of lnc34a, vascular invasion and Barcelona Clinic Liver Cancer (BCLC) stage were associated with bone metastasis by analysis. Moreover, lnc34a expression was specifically associated with bone metastasis rather than lung or lymph node metastasis in HCC.
Conclusions
High serum lnc34a expression was a independent risk factor for developing bone metastasis in HCC.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Biomedical and Life Sciences
/ Cancer
/ DNA
/ Health Promotion and Disease Prevention
/ Hepatoma
/ lnc34a
/ Oncology
/ Reagents
/ RNA
/ Serum
